The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b
- 1 June 2010
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (6), 1971-1980
- https://doi.org/10.1172/jci40380
Abstract
Activated protein C (APC), the only FDA-approved biotherapeutic drug for sepsis, possesses anticoagulant, antiinflammatory, and barrier-protective activities. However, the mechanisms underlying its antiinflammatory functions are not well defined. Here, we report that the antiinflammatory activity of APC on macrophages is dependent on integrin CD11b/CD18, but not on endothelial protein C receptor (EPCR). We showed that CD11b/CD18 bound APC within specialized membrane microdomains/lipid rafts and facilitated APC cleavage and activation of protease-activated receptor–1 (PAR1), leading to enhanced production of sphingosine-1-phosphate (S1P) and suppression of the proinflammatory response of activated macrophages. Deletion of the γ-carboxyglutamic acid domain of APC, a region critical for its anticoagulant activity and EPCR-dependent barrier protection, had no effect on its antiinflammatory function. Genetic inactivation of CD11b, PAR1, or sphingosine kinase–1, but not EPCR, abolished the ability of APC to suppress the macrophage inflammatory response in vitro. Using an LPS-induced mouse model of lethal endotoxemia, we showed that APC administration reduced the mortality of wild-type mice, but not CD11b-deficient mice. These data establish what we believe to be a novel mechanism underlying the antiinflammatory activity of APC in the setting of endotoxemia and provide clear evidence that the antiinflammatory function of APC is distinct from its barrier-protective function and anticoagulant activities.Keywords
This publication has 44 references indexed in Scilit:
- Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cellsJCI Insight, 2009
- Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutantBlood, 2009
- Recombinant human activated protein C inhibits integrin-mediated neutrophil migrationBlood, 2009
- Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial CellsCirculation Research, 2008
- Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in MacrophagesCirculation Research, 2008
- Activated protein C–cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombinBlood, 2008
- Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein CThe Journal of Experimental Medicine, 2007
- Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migrationThe EMBO Journal, 2006
- Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotectiveNature Medicine, 2003